Wk 3 Toxicology

Embed Size (px)

Citation preview

  • 7/31/2019 Wk 3 Toxicology

    1/24

    PC 1.3,1.7,1.8 and element 4 session 3

  • 7/31/2019 Wk 3 Toxicology

    2/24

    Study of poisons Any drugs are potential poisons when used

    improperly or in excess doses Can be:

    Acute

    Chronic

  • 7/31/2019 Wk 3 Toxicology

    3/24

    SKIN Rashes

    Pruritus

    Urticaria

    Photosensitivity

    GIT Discomfort & pain

    Nausea & vomiting

    Diarrhoea

    Assessment -Assessment - Identifysymptoms

  • 7/31/2019 Wk 3 Toxicology

    4/24

    Assessment -Assessment - Identifysymptoms CARDIOVASCULAR

    Abnormalities in cardiac rhythm

    Hypotension or hypertension

    CCF

    Bone marrow depression anaemia

    CNS confusion & irritability

    Alterations in gait

    Tremors

  • 7/31/2019 Wk 3 Toxicology

    5/24

    Assessment -Assessment - Identifysymptoms RENAL

    Electrolyte imbalance

    Urine retention

    Polyuria

    Fluid retention RESPIRATORY SYSTEM

    Dyspnoea

    Asthmatic response

    BILIARY SYSTEM Jaundice

    Impaired LFTs

    Clotting changes

  • 7/31/2019 Wk 3 Toxicology

    6/24

    AssessmentAssessment

    Unusual behaviours Vital signs

    Baseline T, P, R, BP

    CNS symptoms Baseline conscious status alert, orientation

    Coma or even death may result from an OD acute or chronic

  • 7/31/2019 Wk 3 Toxicology

    7/24

    AssessmentAssessment

    Drug monitoring Blood levels e.g. gentamycin

    Therapeutic level Maintained administered at correct time to

    optimize blood levels

    Individualized dosage Lithium; phenytoin; warfarin

    To avoid toxicity Some medications have small safety margin

    before toxicity occurs e.g. digoxin

  • 7/31/2019 Wk 3 Toxicology

    8/24

  • 7/31/2019 Wk 3 Toxicology

    9/24

  • 7/31/2019 Wk 3 Toxicology

    10/24

    Four common medications

    Paracetamol Analgesic mild pain

    Digitalis Cardiac glycoside

    Morphine Opiate analgesic severe pain

    Warfarin

    Anticoagulant

  • 7/31/2019 Wk 3 Toxicology

    11/24

    Toxicity paracetamol

    Most common OTC worldwide Most common paediatric accidental exposure 8 grams can be a toxic level i.e. 16 tablets Rapidly absorbed from the small intestine Peak serum concentrations within:

    1 2 hours of taking tablet formulation

    30 minutes for liquid preparations

    20% of ingested paracetamol undergoes 1st pass

    metabolism Distribution within 4/24 of ingestion for tablet &

    2/24 for liquid

  • 7/31/2019 Wk 3 Toxicology

    12/24

    Toxicity paracetamol

    Half-life 1.5 3 hours General principals of OD

    Resuscitation rarely required for an acute OD

    Supportive management

    Accidental Deliberate

    Risk Assessment

    Dose taken

    Concentration Laboratory report suggestive of liver damage

    Serum levels will indicate ifN-acetylcysteine required prevents/reduces liver damage

  • 7/31/2019 Wk 3 Toxicology

    13/24

    Toxicity paracetamol

    Management- single accidental ingestion Children under 6 with observe

    Seldom requires any other treatment

    Adults 50 gram activated charcoal within 1 2

    hours of ingestionTime of ingestion will alter managementType of preparation sustained release has

    potential for slow absorption Gastric lavage may be required

  • 7/31/2019 Wk 3 Toxicology

    14/24

    Toxicity paracetamol

    Subsequent management May develop severe hepatotoxicity and liver

    failure

  • 7/31/2019 Wk 3 Toxicology

    15/24

    Toxicity digitalis

    Symptoms include: EyesBlurred vision, halos around objects

    Allergic skin reaction

    Hives, rash GITDiarrhoea, loss of appetite, nausea, stomach pain,

    vomiting

    Cardiac & blood

    Irregular heartbeat, weakness Nervous systemConfusion, depression, drowsiness, fainting,

    hallucinations, headache, lethargy

  • 7/31/2019 Wk 3 Toxicology

    16/24

    Toxicity digitalis

    Symptomatic treatment, may include: Activated charcoal

    ECG digitalis depression in the QRS complex

    Blood levels for digoxin, magnesium, potassium

    Correction of electrolyte imbalances

    Breathing support

    Dialysis

    Gastric lavage

  • 7/31/2019 Wk 3 Toxicology

    17/24

    Toxicity morphine

    Long term use patient tolerance increases Overdose symptoms:

    Cyanosis - fingernails & lips

    Cold, clammy skin

    Constipation

    Convulsions

    Dizziness, fainting

    Itching skin

    Slow, shallow respiration rate

    BP

    Weak pulse

  • 7/31/2019 Wk 3 Toxicology

    18/24

    Toxicity morphine

    Overdose symptoms ctd: Muscle spasms

    Sedation

    Skeletal muscle flaccidity

    Pinpoint pupils

    Coma

    IF patient is Comatose, has pinpoint pupils & shallow, short,

    respirations or has stopped breathing requiresCPR and narcain ASAP to reverse effect onrespiratory system

  • 7/31/2019 Wk 3 Toxicology

    19/24

    Toxicity morphine

    Other drugs that affect morphine include: Sedatives

    Tranquillizers

    Muscle relaxants

    May increase the side effects of morphine

  • 7/31/2019 Wk 3 Toxicology

    20/24

    Toxicity warfarin

    Anticoagulant Reduces the prothrombin (PT) i.e. the time it

    takes the blood to clot

    Commonly used to treat blood clots due tovarious causes Most important effect of warfarin OD is

    bleeding

    Nosebleeds, bright blood in stools, vomiting, easybruising, cuts take longer to stop bleeding

    Antidote Vitamin K

  • 7/31/2019 Wk 3 Toxicology

    21/24

    Toxicity warfarin

    Patients on long term therapy requiremonitoring

    INR (International Normalized Ratio) 2.0 - 3.0desirable range (2.5 optimal)

    Patient may be on medication 6/52 6/12 Patients > 75 at greater risk of intracranial

    bleeding when taking warfarin so the INR

    target level usually reduced & can be as lowas 1.5 2.0

  • 7/31/2019 Wk 3 Toxicology

    22/24

    Toxicity warfarin

    Factors that effect dosage include: Old age, reduced body weight, impaired cardiac

    function, impaired liver function

    Drug interactions that can prolong the

    PT e.g. Allopurinol

    Chloramphenacol

    Cimetidine

    Ciprofloxacin

    Metronidazole

    tamoxifen

  • 7/31/2019 Wk 3 Toxicology

    23/24

    Toxicity warfarin

    Drug interactions that can interferewith protein binding e.g. Chloral hydrate; salicylates

    Drug interactions that can reduce PT by

    decreasing the effect of warfarin e.g. Inhibition of warfarin absorptionAluminum hydroxide; colestipol

    Enhanced warfarin metabolismBarbiturates; phenytoin

    Promote Vitamin K activityFoods with high Vitamin K content (>200 mcg) e.g.

    brussel sprouts; chick peas; parsley; red leaf lettuce

  • 7/31/2019 Wk 3 Toxicology

    24/24

    Toxicity warfarin

    Emergency Treatment includes: Activated charcoal Baseline PT/INR

    Blood transfusion if significant blood loss May require transfusion of clotting factors II,

    VII, IX & X Vitamin K used if evidence of anticoagulation

    exists. Dose varies with clinical situation,amount taken type i.e. short or long acting